Shireen has dedicated the last decade of her life to a detailed understanding of the biology of cancer, auto-immune, dermatology and infectious disease. As Co-founder and Chief Scientific Officer of Cellworks Group, Dr. Shireen Vali has been instrumental in building the Cellworks R&D organization spanning multiple disease indications from initiation to size of over 125. Under her leadership Cellworks’ in-vivo equivalent technology representing disease physiology has grown to over a million signaling and metabolic cross talk interactions.
Dr. Shireen Vali also oversees the development pipeline of therapeutic programs for cancer , ensuring Cellworks stays at the forefront of innovation and therapy.
She brings over two decades of experience in molecular and cellular biology research and development to the company. Dr. Shireen Vali holds a PhD, Neuroscience from U.C. Davis and has completed her fellowship at Stanford University. She has co-authored and presented tens of articles in scientific publications and industry conferences worldwide.